Bank Of Nova Scotia Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bank Of Nova Scotia

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $70,590 - $74,165	487 Added 9.99%	5,364 $811,000
Q2 2022 Aug 08, 2022	BUY	$83.14 - $145.99 $405,473 - $711,993	4,877 New	4,877 $711,000
Q2 2022 Aug 05, 2022	SELL	$83.14 - $145.99 $440,558 - $773,601	-5,299 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$110.08 - $142.92 $294,574 - $382,453	-2,676 Reduced 33.55%	5,299 $628,000
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $795,346 - $1.18 Million	7,975 New	7,975 $1.11 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.